Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2024

Feb 14, 2024

29745_dirs_2024-02-14_434ddc33-2cf3-404d-9c4c-55a8440955bb.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2024-02-12

Reporting Person: Hakim Anat (EVP, GC & Secretary)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-02-12 Common Stock A 5815 $737.26 Acquired 30479 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-02-12 Restricted Stock Unit $ A 4904 Acquired 2025-02-01 Common Stock (4904) Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.